Delving into Securities Filings - Part 1: 27 Drug Makers’ Workforce Down 0.5% as Major Firms Continue to Shed Jobs

By Reiji Anasako Japanese drug makers have completed the submission of their securities reports for FY2016 after most of them closed their books in March 2017. This two-part series looks into these filings to give a deeper insight into salary...read more